Oragenics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Oragenics generated cash of -$7,290,880, which is more than the previous year. Cash used in financing activities reached the amount of $283,880 last year. Net change in cash is therefore -$7,943,284.
Cash Flow
| 2014 | -5.55M | -110.24K | -158.21K |
|---|---|---|---|
| 2015 | -5.10M | -101.23K | -159.95K |
| 2016 | -7.07M | 1.67M | 4.45M |
| 2017 | -6.36M | 0 | 8.44M |
| 2018 | -9.07M | -124.72K | 23.24M |
| 2019 | -13.01M | -25.21K | 11.09M |
| 2020 | -16.95M | 0 | 16.32M |
| 2021 | -13.47M | -43.87K | 23.14M |
| 2022 | -15.22M | -115.51K | -494.91K |
| 2023 | -7.29M | -936.28K | 283.88K |
OGEN Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 11.42M | 27.26M | 17.63M | 18.26M | 20.20M | 6.16M | 4.08M | 5.08M | 10.44M | 16.27M |
Operating activities | ||||||||||
Net income | -20.65M | -14.28M | -15.71M | -26.43M | -15.56M | -9.91M | -6.73M | -7.01M | -11.71M | -5.78M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 27.39K | 44.66K | 41.23K | 51.70K | 62.62K | 30.11K | 65.80K | 75.04K | 71.15K | 27.66K |
Stock-based compensation expense | 1.01M | 742.20K | 1.68M | 1.49M | 552.99K | 1.02M | 560.47K | 638.41K | 1.03M | 287.03K |
| Deferred income tax benefit | 1.01M | 742.20K | 1.68M | 1.49M | 552.99K | 1.02M | 560.47K | 638.41K | 1.03M | 287.03K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 6.98K | -6.98K | 0 | 0 | 0 | 0 | 0 | -5.50K | 48.82K |
Inventories | 0 | -6.98K | 6.98K | 0 | 0 | 0 | 0 | 0 | 117.68K | -150.80K |
Accounts payable | 25.79K | 176.62K | 10.55K | -603.73K | 498.05K | 225.31K | 525.77K | 446.03K | 331.08K | -199.74K |
Cash generated by operating activities | -7.29M | -15.22M | -13.47M | -16.95M | -13.01M | -9.07M | -6.36M | -7.07M | -5.10M | -5.55M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -127.51K | -43.87K | 0 | -25.21K | -124.72K | 0 | -27.17K | -102.51K | -110.67K |
Acquisitions Net | 0 | 12K | 0 | 0 | 0 | 0 | 0 | 1.45M | 1.28K | 0 |
Cash generated by investing activities | -936.28K | -115.51K | -43.87K | 0 | -25.21K | -124.72K | 0 | 1.67M | -101.23K | -110.24K |
Financing activities | ||||||||||
Common Stock Issued | 849.92K | 69.28K | 29.30M | 16.52M | 11.35M | 0 | 6.17M | 2.64M | 99 | 135 |
Payments for dividends | 0 | 0 | 0 | 0 | -413.21K | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -5.63M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -524.98K | -197.33K | 0 | 0 | 2.24M | -158.1K | -159.95K | -158.21K |
Cash used in financing activities | 283.88K | -494.91K | 23.14M | 16.32M | 11.09M | 23.24M | 8.44M | 4.45M | -159.95K | -158.21K |
Net Change In Cash | -7.94M | -15.83M | 9.62M | -628.41K | -1.94M | 14.04M | 2.08M | -1.00M | -5.36M | -5.82M |
Cash at end of period | 3.48M | 11.42M | 27.26M | 17.63M | 18.26M | 20.20M | 6.16M | 4.08M | 5.08M | 10.44M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |